National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
NCAB Meeting Presentations

Presentations from the 140th Meeting Held November 30 - December 1, 2006
(Presentation File Format - PDF --> Get Adobe Reader)

November 30
NIH VIDEOCAST  
Director's Update Dr. Niederhuber
NCI Legislative Update Ms. Erickson
Overview: Frederick Cancer Research and Development Center Dr. Reynolds

Center for Cancer Research: Meeting NIH's Mandate for Rare Disease Research  
Clinical Development of Treatments dfor Neurofibromatosis Type I Associated Tumors Dr. Widemann

Center for Cancer Research: Immunology Center of Excellence  
Preclinical and Clinical Development of a Potent Vaccine Adjuvant and Immunorestorative --or-- From IL-2 to IL-7 Dr. Mackall
The Biology of IL-15 and IL-2: Implications for Cancer Therapy and Vaccine Design Dr. Waldmann
A Promising Candidate to Enhance Vaccine Efficacy Against Cancer and HIV: IL-15 Dr. Berzofsky

Center for Cancer Research: Profiling and Gene Regulation  
Routine Molecular Diagnosis of Cancer in Clinical Oncology Dr. Staudt
Malignant Gliomas and Neural Stem Cells Gone Bad: The Biological and Therapeutic Implications of a Changing Paradigm Dr. Fine
Deciphering the Genetic Barcode of Cancer Susceeptibility using Mouse Models of Astrocytoma, MPNST, and NF1 Dr. Reilly

December 1
NIH VIDEOCAST  

Program Review of Division of Cancer Epidemiology and Genetics: Melding Epidemiology and Genomics  
From High-Risk Families to Populations Dr. Fraumeni
Key Epidemiologic Challenges Dr. Hoover
Clues from the Pathway-Driven Approach Dr. Garcia-Closas
The Promise of Genome-wide Association Studies (GWAS) Dr. Chanock

Breast Cancer Stamp Program  
NCI Breast Pre-Malignancy Program Dr. Fraumeni
CCR Breast Cancer Stamp Fund Program Dr. Vnderhaar